MENU
+Compare
PMVP
Stock ticker: NASDAQ
AS OF
Jun 12, 04:59 PM (EDT)
Price
$1.07
Change
-$0.06 (-5.31%)
Capitalization
58.71M

PMVP PMV Pharmaceuticals Forecast, Technical & Fundamental Analysis

PMV Pharmaceuticals Inc is a precision oncology company... Show more

PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PMVP with price predictions
Jun 11, 2025

PMVP in upward trend: price rose above 50-day moving average on June 06, 2025

PMVP moved above its 50-day moving average on June 06, 2025 date and that indicates a change from a downward trend to an upward trend. In of 27 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 05, 2025. You may want to consider a long position or call options on PMVP as a result. In of 111 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PMVP just turned positive on May 20, 2025. Looking at past instances where PMVP's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for PMVP crossed bullishly above the 50-day moving average on June 10, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where PMVP advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PMVP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PMVP broke above its upper Bollinger Band on June 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PMVP entered a downward trend on May 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.367) is normal, around the industry mean (16.733). P/E Ratio (0.000) is within average values for comparable stocks, (59.866). PMVP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.287). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (259.374).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PMVP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PMVP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PMVP is expected to report earnings to rise 16.18% to -39 cents per share on August 07

PMV Pharmaceuticals PMVP Stock Earnings Reports
Q2'25
Est.
$-0.40
Q1'25
Beat
by $0.03
Q4'24
Missed
by $0.08
Q3'24
Missed
by $0.02
Q2'24
Beat
by $0.33
The last earnings report on May 09 showed earnings per share of -34 cents, beating the estimate of -37 cents. With 204.23K shares outstanding, the current market capitalization sits at 58.71M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Research Way
Phone
+1 609 642-6670
Employees
63
Web
https://www.pmvpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRCA0.620.02
+3.66%
Verrica Pharmaceuticals
QCOM159.480.35
+0.22%
QUALCOMM
VIGL7.86-0.02
-0.25%
Vigil Neuroscience
LZB40.26-0.96
-2.33%
La-Z-Boy
SPSC136.21-8.29
-5.74%
SPS Commerce

PMVP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with XNCR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
-5.04%
XNCR - PMVP
42%
Loosely correlated
-2.26%
COGT - PMVP
39%
Loosely correlated
-2.16%
CLLS - PMVP
39%
Loosely correlated
+1.40%
VERV - PMVP
38%
Loosely correlated
+0.08%
CCCC - PMVP
36%
Loosely correlated
-3.18%
More